Cargando…

Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients

BACKGROUND: Tumor Associated Antigens are characterized by spontaneous immune response in cancer patients as a consequence of overexpression and epitope-presentation on MHC class I/II machinery. Matrix Metalloprotease 11 (MMP11) expression has been associated with poor prognosis for several cancer t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roscilli, Giuseppe, Cappelletti, Manuela, De Vitis, Claudia, Ciliberto, Gennaro, Di Napoli, Arianna, Ruco, Luigi, Mancini, Rita, Aurisicchio, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936832/ https://www.ncbi.nlm.nih.gov/pubmed/24564996 http://dx.doi.org/10.1186/1479-5876-12-54

Ejemplares similares

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
por: Noto, Alessia, et al.
Publicado: (2013)

The promise of anti-ErbB3 monoclonals as new cancer therapeutics
por: Aurisicchio, Luigi, et al.
Publicado: (2012)

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
por: Fattore, Luigi, et al.
Publicado: (2015)

Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment
por: Mancini, Rita, et al.
Publicado: (2011)

Are Genetic Vaccines the Right Weapon against COVID-19?
por: Conforti, Antonella, et al.
Publicado: (2020)

Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
por: Fattore, Luigi, et al.
Publicado: (2013)

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression
por: Ciardiello, Chiara, et al.
Publicado: (2016)

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
por: Fattore, Luigi, et al.
Publicado: (2015)

Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition
por: Fattore, Luigi, et al.
Publicado: (2014)

Emerging Cancer Vaccines: The Promise of Genetic Vectors
por: Aurisicchio, Luigi, et al.
Publicado: (2011)

SCD1, autophagy and cancer: implications for therapy
por: Ascenzi, Francesca, et al.
Publicado: (2021)

The natural compound fucoidan from New Zealand Undaria pinnatifida synergizes with the ERBB inhibitor lapatinib enhancing melanoma growth inhibition
por: Thakur, Varsha, et al.
Publicado: (2017)

Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity
por: Roscilli, Giuseppe, et al.
Publicado: (2016)

Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells
por: Noto, A, et al.
Publicado: (2013)

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma
por: Gavazza, Alessandra, et al.
Publicado: (2013)

The perfect personalized cancer therapy: cancer vaccines against neoantigens
por: Aurisicchio, Luigi, et al.
Publicado: (2018)

Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance
por: VESCI, LOREDANA, et al.
Publicado: (2015)

Cancer Stem Cells and the Slow Cycling Phenotype: How to Cut the Gordian Knot Driving Resistance to Therapy in Melanoma
por: Fattore, Luigi, et al.
Publicado: (2020)

Reduced lymphotoxin‐beta production by tumour cells is associated with loss of follicular dendritic cell phenotype and diffuse growth in follicular lymphoma
por: Pepe, Giuseppina, et al.
Publicado: (2018)

A novel minigene scaffold for therapeutic cancer vaccines
por: Aurisicchio, Luigi, et al.
Publicado: (2014)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
por: Aurisicchio, Luigi, et al.
Publicado: (2020)

Single cell analysis to dissect molecular heterogeneity and disease evolution in metastatic melanoma
por: Fattore, Luigi, et al.
Publicado: (2019)

Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
por: Salvatori, Erika, et al.
Publicado: (2022)

Rituximab Plus Chemotherapy Provides No Clinical Benefit in a Peripheral T-Cell Lymphoma not Otherwise Specified with Aberrant Expression of CD20 and CD79a: A Case Report and Review of the Literature
por: Mangogna, Alessandro, et al.
Publicado: (2020)

Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma
por: Impellizeri, Joseph A., et al.
Publicado: (2018)

Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants
por: Massacci, Alice, et al.
Publicado: (2020)

CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions
por: Bruschini, Sara, et al.
Publicado: (2019)

Deconvolution of malignant pleural effusions immune landscape unravels a novel macrophage signature associated with worse clinical outcome in lung adenocarcinoma patients
por: Bruschini, Sara, et al.
Publicado: (2022)

B4GALT1 as a New Biomarker of Idiopathic Pulmonary Fibrosis
por: De Vitis, Claudia, et al.
Publicado: (2022)

The emerging role of cancer cell plasticity and cell-cycle quiescence in immune escape
por: Bruschini, Sara, et al.
Publicado: (2020)

The Promise of Liquid Biopsy to Predict Response to Immunotherapy in Metastatic Melanoma
por: Fattore, Luigi, et al.
Publicado: (2021)

Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
por: Lione, Lucia, et al.
Publicado: (2021)

IL-10, IL-13, Eotaxin and IL-10/IL-6 ratio distinguish breast implant-associated anaplastic large-cell lymphoma from all types of benign late seromas
por: Di Napoli, Arianna, et al.
Publicado: (2020)

Drug repurposing against COVID-19: focus on anticancer agents
por: Ciliberto, Gennaro, et al.
Publicado: (2020)

An efficient T-cell epitope discovery strategy using in silico prediction and the iTopia assay platform
por: Fridman, Arthur, et al.
Publicado: (2012)

B4GALT1 Is a New Candidate to Maintain the Stemness of Lung Cancer Stem Cells
por: De Vitis, Claudia, et al.
Publicado: (2019)

H-Ras gene takes part to the host immune response to COVID-19
por: Sciacchitano, Salvatore, et al.
Publicado: (2021)

Intra-tumor AvidinOX allows efficacy of low dose systemic biotinylated Cetuximab in a model of head and neck cancer
por: Vesci, Loredana, et al.
Publicado: (2015)

Histologic Analysis of Idiopathic Pulmonary Fibrosis by Morphometric and Fractal Analysis
por: Mancini, Massimiliano, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b1fq6po4i3ts989h3j1fiqhrc4